GVK BioSciences Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • GVK BioSciences's estimated annual revenue is currently $267.8M per year.(i)
  • GVK BioSciences's estimated revenue per employee is $142,800

Employee Data

  • GVK BioSciences has 1875 Employees.(i)
  • GVK BioSciences grew their employee count by -4% last year.

GVK BioSciences's People

NameTitleEmail/Phone
1
VP Sales/MarketingReveal Email/Phone
2
Senior scientific managerReveal Email/Phone
3
Senior Scientific ManagerReveal Email/Phone
4
Special Advisor to the BoardReveal Email/Phone
5
General Manager Business DevelopmentReveal Email/Phone
6
Senior executive ProductionReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M176%N/AN/A
#2
$13.4M13110%N/AN/A
#3
$42.8M3360%N/AN/A
#4
$7.8M760%N/AN/A
#5
$8.2M803%N/AN/A
#6
$0.1M6-25%$1.9MN/A
#7
$5.7M6211%N/AN/A
#8
$0.9M140%N/AN/A
#9
$25.2M2257%N/AN/A
#10
$6.3M7113%$1.7MN/A
Add Company

What Is GVK BioSciences?

We are committed to open, transparent communication that fosters long term partnerships. We recognize that each client and program is as unique as the products they aim to create. We take the time and effort to understand preferences and working styles, so our clients maximize the benefits from collaboration.

keywords:N/A

N/A

Total Funding

1875

Number of Employees

$267.8M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GVK BioSciences News

2022-04-19 - In-Silico Drug Discovery Market: Involved Key Players Will ...

GVK Biosciences Private Limited ? Novo Informatics Pvt. Ltd. Market Segments by Type: ? Proteins ? Antibodies ? Nucleic Acids

2022-04-17 - Global Drug Repositioning Service Market 2022 Development ...

Biovista; Anaxomics Biotech; Segue Therapeutics; GVK Biosciences; LTT Bio-Pharma. Customization of the Report: This report can be customized to...

2022-04-17 - Clinical Research Organisation (CRO) Market Opportunities ...

Research Report includes Charles River Laboratories, IQVIA, LabCorp, Domainex, Evotec AG, Genscript Biotech, GVK Biosciences,...

2015-12-02 - India: PE firm ChrysCapital to buy Sequoia’s 10% stake in GVK Bio for $25m

Premium Private equity firm ChrysCapital is buying a 10% stake in Hyderabad-based contract research company GVK Biosciences for about $25 million, as per a report in The Times of India. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in ...

2015-12-02 - India: PE firm ChrysCapital to buy Sequoia’s 10% stake in GVK Bio for $25m

Premium Private equity firm ChrysCapital is buying a 10% stake in Hyderabad-based contract research company GVK Biosciences for about $25 million, as per a report in The Times of India. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$376.5M1921N/AN/A
#2
$487.9M1936-10%N/A
#3
$742.8M19656%N/A
#4
$765.4M19881%N/A
#5
$707.6M2063-3%N/A